Previously, we described cloning of three alternatively spliced mRNA forms of human FGF8, a, b, and e, of which the b form is the major expressed species in both normal and tumor prostatic epithelial cells. In this report, we describe construction and overexpression of sense and antisense sequences of either the full length FGF8b coding region (215-amino acids or 215aa), 103aa N-terminal part or a smaller N-terminal region (34aa), each including the 23aa putative signal peptide domain, via a retrovirus system. While the morphologic transforming activities of the sense 215aa and 103aa constructs were similar in NIH3T3 cells, 103aa displayed reduced soft agar clonogenic activity. The 34aa construct was practically inert in these assays, although its expression could mimic the ability of 215aa or 103aa in conferring cell growth under reduced serum condition. Overexpression of any of the three constructs in antisense orientation, however, was similarly eective in reversing the morphology and anchorage-independent growth property of FGF8b-transfected NIH3T3 cells. The expression of the antisense 215aa construct signi®cantly reduced the growth rate of the human prostatic carcinoma DU145 cells and inhibited their soft agar clonogenic activity and in vivo tumorigenicity in nude mice. Taken together, these results identify Nterminal portions of FGF8 protein isoform for having the domains necessary for one or more of the biologic eects examined, and suggest that low levels of FGF8 expressed in prostatic epithelial cells may contribute signi®cantly to their growth and tumorigenic properties.
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Keywords: FGF8; antisense RNA; prostate cancer cells; retroviral vector Polypeptide mitogens, classi®ed as the family of ®broblast growth factors (FGFs), consist of 12 members (FGF1 ± FGF12) identi®ed to date, which share only 30 ± 45% amino acid sequence homology. They also have some common physical properties such as the ability to bind heparin and heparan sulfate proteoglycans. Most FGF proteins are secreted and their eects as extracellular components are mediated by a complex system of FGF receptor (FGFR) tyrosine kinases either through autocrine or paracrine mechanisms (Basilico and Moscatelli, 1992; Johnson and Williams, 1993; Mason, 1994; Coulier et al., 1997; Verdier et al., 1997) . FGF8 was originally isolated from the conditioned medium of an androgendependent Shionogi mouse mammary carcinoma, SC-3, cell line (Tanaka et al., 1992) . The expression of this growth factor has been correlated with murine embryogenesis in gastrulation, regionalization of the brain, and organogenesis of limbs, face and tail bud (Crossley and Martin, 1995; Heikinheimo et al., 1994; Ohuchi et al., 1994; Mahmood et al., 1995; Crossley et al., 1996) . In the adult mouse tissues expression of FGF8 is generally weak but readily detected in testes and ovaries (MacArthur et al., 1995c; Lorenzi et al., 1995) . Compared to other mammalian FGF genes, murine Fgf8 gene is most complicated in its`®rst' coding exon which, in fact, consists of at least four dierent exons. This contributes to a complex alternative splicing phenomenon that generates transcripts with coding potential for at least seven secreted FGF8 proteins varying in their NH 2 -termini (Tanaka et al., 1992; Crossley and Martin, 1995; MacArthur et al., 1995a,c) . The structure of the human FGF8 gene localized to chromosome 10q25-q26 (Lorenzi et al., 1995; White et al., 1995; Payson et al., 1996) , however, appears to be slightly less complex with potential for only four FGF8 protein isoforms Gemel et al, 1996) . Of these four possible isoforms, three were previously cloned in our laboratory (Ghosh et al., 1996) . The protein products of these cDNA clones, designated FGF8a, FGF8b and FGF8e, dier from each other at the NH 2 -terminal region of the mature proteins and share extensive nucleotide sequence homology in the protein coding region to the corresponding mouse cDNA isoforms.
The human FGF8 isoforms, although only weakly expressed in human adult tissues or cell lines, are nevertheless dierentially overexpressed. For example, while expression of both FGF8a and FGF8b messenger RNAs is detected in kidney and testes, FGF8b appears to be the primary species in the prostatic tissue and in normal and tumor prostatic cell lines (Ghosh et al., 1996) . Interestingly, consistent with the reports of robust transforming and tumorigenic activity of mouse FGF8b (MacArthur et al., 1995a; Kouhara et al., 1994) , the human FGF8b, but not FGF8a or FGF8e, displays similarly strong activities (Ghosh et al., 1996) . This oncogenic activity becomes more relevant when new evidence points to a signi®cant up-regulation of FGF8 mRNA expression in high-grade prostate carcinomas (Leung et al., 1996) . Aims of the present study were to (i) begin an analysis to de®ne the Nterminal regions of the FGF8b protein isoform required for induction of cell transformation; (ii) develop antisense vectors to eciently block the functions induced by FGF8b isoform; and (iii) evaluate the eect of antisense expression in the context of a prostatic carcinoma cell line.
To explore the distribution of the functional domains on the human FGF8 isoform b molecule, the full length polypeptide (215aa), an N-terminal portion (103aa) or a smaller N-terminal peptide (34aa) was overexpressed in NIH3T3 cells by retroviral gene transduction. The 23 amino acid long signal peptide sequence was retained in each construct so that the expressed protein molecules could enter the secretory pathway. A retrovirus vector, WZLneo (Freytag et al., 1994) which contains an internal ribosome entry site (IRES) from the encephalomyocarditis virus in front of a selection marker gene was used for the expression of each of the 215aa, 103aa and 34aa molecules ( Figure  1 ). The constructs of 103aa and 34aa also included a translation stop codon which is naturally present in the 215aa sequence (Ghosh et al., 1996) . As designed the mature protein of the 103aa construct should contain the N-terminal one-third of the conserved`core' region common to all FGFs (Basilico and Moscatelli, 1992) along with upstream 32 amino acids of which the Nterminal 11 amino acids are speci®c for the FGF8b isoform (Ghosh et al., 1996) . The mature peptide of the 34aa construct should include only the 11 amino acid moeity speci®c for the FGF8b isoform when compared to the other two isolated human isoforms, namely, FGF8a and FGF8e (Ghosh et al., 1996) . The parental (WZLneo) and the three FGF8b retroviral vectors were used to transfect PA317 amphotropic cells and G418 resistant colonies were isolated. The cell clones which produced relatively higher virus titers were selected and their supernatant culture¯uids used to infect NIH3T3 cells. Again, stable transfectants were selected with G418; and pooled, rather than individual colonies, were examined to avoid potential atypical representation due to clonal variation. Both the 215aa and 103aa infected cells displayed striking morphologic changes, while the vector control or the 34aa virus infected cells were roughly equal in phenotype to each other or to parental NIH3T3 cells (Figure 2 ). The clonogenic eciency, however, was not the same for the 215aa and 103aa cells. Expression of full length FGF8b resulted in an average colony forming eciency of 4.5%, while that of the 103aa was consistently lower with a value of 3.2% (Table 1) . Additionally, colonies induced by the expression of 103aa polypeptide were, in general, of smaller sizes compared to those induced by the complete factor.
Because FGFs are known to promote growth in serum-free medium (Johnson and Williams, 1993) , and Figure 2 Morphological transformation of NIH3T3 cells by FGF8b constructs. NIH3T3 cells were infected with the three dierent constructs of FGF8b along with the vector control, G418 resistant colonies were pooled and grown to determine morphological changes as described (Ghosh et al., 1996) . Both 215aa and 103aa constructs presented strong morphological transformation but the 34aa construct did not show any morphological changes. (a) vector control; (b) 215aa; and (c) 103aa. The morphology of 34aa transduced cells was similar to vector control cells particularly, since murine FGF8b was demonstrated earlier to be capable of supporting growth of NIH3T3 cells in reduced serum medium (MacArthur et al., 1995b) , it was of interest to examine this property with respect to the truncated polypeptides of FGF8b. In medium supplemented with 0.1% fetal bovine serum, parental NIH3T3 cells or the vector virus infected NIH3T3 cells died between 24 ± 48 h after the onset of serum deprivation. The 215aa and 103aa producing cells, on the other hand, continued to grow without any signi®cant amount of cell death up to the observation period of 10 days; and, as expected, these cells displayed the typical transformed morphology. The 34aa virus infected cells appeared to grow well at least for 5 days in 0.1% serum, and then by the 6th day, the cells began tō oat denoting cell death (Table 1) . NIH3T3 cells transformed by FGF8b in the pcDNA3 expression vector were separately infected with antisense virus constructs of 215aa, 103aa and 34aa and examined for morphologic phenotype after three rounds of infection and propagation in culture for 4 days. Each of the constructs was quite eective in reversing the morphology of the FGF8b-transformed NIH3T3 cells from the elongated spindle-shaped types to that mimicking the phenotype of vector only control NIH3T3 cells, that is, generally¯at ®broblastic appearance. These results with 215aa and 103aa antisense constructs relative to FGF8b-transformed NIH3T3 cells are represented in Figure 3 (a ± c). Similar phenotype reversion was observed with the 34aa antisense construct (data not shown). The fact that WZLneo vector-based antisense RNAs (2.9 ± 3.2 kb) were indeed expressed and that their expression downregulated the 0.8 kb pcDNA3-based FGF8b mRNA expressed is illustrated in Figure 3d . The extent of downregulation was seemingly contrasting as the For the soft agar clonogenicity assay, infected and selected cells were suspended in 0.4% Seakem agarose in DMEM with 10% FBS (®nal concentration) at a cell density of 10 4 per 2 ml. The suspension was overlayed on 4 ml of 0.8% Seakem agarose in DMEM containing 10% FBS (®nal concentration) in a 6 cm dish, and the cultures were incubated at 378C and 5% CO 2 for 21 days. The visible colonies were counted at that point, and the colony forming eciency was calculated by dividing the number of soft agar colonies formed by the number of cells plated and multiplied by 100 to convert to percentages. For growth in reduced serum, cells (5610 5 ) were plated in 10 cm petridishes overnight; next day washed twice with serum free media and switched to DMEM containing 0.1% FBS. The cells were maintained and observed up to 10 days. Morphological changes induced by the serum switch, most notably, loss of anchorage attachment to the culture plate was documented by photomicroscopy and trypan blue exclusion counting Human FGF8 function N Rudra-Ganguly et al detected levels of antisense transcripts were low. There is, however, evidence that stability of antisense RNA depends on its primary structure, and in most cases the stability is low (Gibson, 1996; Kobayashi et al., 1995) . Furthermore, the half-life of the duplex RNA formed between antisense RNA and target RNA could be extremely short relative to single strands (Junker et al., 1994) . The ability of the antisense treated NIH3T3-FGF8b cells to form colonies in soft agar was also examined. The clonagenic eciency of the NIH3T3-FGF8b cells was drastically reduced by the expression of either of the three antisense constructs (data not shown). There was practically no dierence in the eciency of the antisense treated cells and that of vector only infected parental 3T3 cells. DU145 human prostate carcinoma cells which were previously shown to express FGF8 isoforms at low levels (Ghosh et al., 1996) were infected with either the sense 215aa or the antisense 215aa virus. Infected cells were selected for G418 resistance, and the pooled colonies were compared for their proliferative properties. As shown in Figure 4 , at low cell density, expression of the antisense RNA resulted in a reduction in the rate of growth by approximately 40 ± 50% as compared to the vector virus infected/ selected cultures. The expression of the sense RNA, however, did not enhance the proliferation ability at any great extent (data not shown); at most a 10 ± 15% increase over the vector virus control was noted at low cell density whose signi®cance could not be ascertained unless the studies are repeated with synchronized cell populations. To con®rm the expression of the sense or antisense RNA in the infected and selected DU145 cell populations we conducted Northern blot analysis with a FGF8b cDNA probe. These results, shown in Figure  5 , indicated a readily detectable and appropriate size RNA bands in both sense and antisense virus infected cells. As described before, DU145 did not express enough quantity of endogenous FGF8 RNAs (1.2 kb) which could be detected by Northern blots, although by RT ± PCR their presence was readily con®rmed (Ghosh et al., 1996) . In this regard, lack of detection of FGF8 RNA in the vector virus infected DU145 cells by Northern blot was not unexpected. What was interesting, however, was the stabilization of the endogenous 1.2 kb RNA species by the overexpression of 3.2 kb sense RNA. This was probably related to reduced turnover of the endogenous FGF8 mRNA in the presence of the expressed 3.2 kb species. The observed dierence in the levels of expression between WZLneo vector-based expression of sense and antisense RNAs was presumably due to polyribosomal stabilization of the sense species and instability of the antisense RNA or its double-stranded forms. However, we did not have any direct evidence to support these contentions. The fact that 215aa sense RNA was translated into a functional protein which entered the secretory pathway in DU145 cells was con®rmed by our NIH3T3 transformation assay with the conditioned medium (Ghosh et al., 1996) .
We also determined whether induced expression of FGF8b antisense RNA could have a negative eect on the clonogenic eciency of the parental DU145 cells. A parallel analysis of sense virus infected, antisense virus infected, and vector only virus infected DU145 cells revealed a signi®cant reduction in clonogenic eciency of the vector control DU145 cells due to expression of the antisense 215aa RNA. While the control cells showed an eciency of 4.2%, the antisense treated cells displayed only 2.2% eciency. Moreover, sizes of the colonies formed with antisense expressing DU145 cells were considerably smaller than the control DU145 colonies. The expression of the sense 215aa RNA in DU145 cells led to a small increase as these consistently showed an eciency of 4.7% compared Table 2 , one of the ®ve mice receiving vector only DU145 cells and three of the ®ve receiving sense 215aa virus-transduced DU145 cells produced palpable tumors 7 days after inoculation. Then, by 14 days, all of the animals in these two groups developed tumors. In contrast, none in the antisense 215aa-DU145 group produced palpable tumors after 7 days. On day 14, two animals were found to have tumors, and a third one produced tumor with a longer latency of approximately 35 days. The other two mice were free of tumors up to 35 days postinoculation when the experiment was terminated, and the tumors were excised out and their volumes measured. The tumor volumes displayed a broad range, and a tumor in the control group measured larger because of a bulging cyst. Although mean volume for the antisense group appeared smaller than the other two groups, no signi®cance could be drawn due to the small number of animals used in the experiments. The tumor latency results and lack of tumor development in two out of the ®ve antisense group animals, however, provided evidence that expression of antisense FGF8 in DU145 cells could inhibit tumorigenicity.
In conclusion, the sense constructs of FGF8b used for the biological assays in the present study were designed to produce polypeptides of 215 amino acid residues, 103 residues and 34 residues. Since the last two constructs are deleted in the 3'-end of the cDNA, the mature proteins without the signal peptide sequence encoded by the three constructs are expected to represent 192 amino acids, its N-terminal 80 amino acids, and its N-terminal 11 amino acid portion, respectively. As the N-terminal 11 amino acid residues constitute the only dierence between FGF8b and FGF8a (Ghosh et al., 1996) , the robust biological activity of FGF8b relative to FGF8a must be related to this 11 amino acid stretch in the context of the total protein molecule. However, the 11 aminio acid peptide alone is not expected to provide the conformation necessary to eectively activate FGF receptors. Moreover, the`core' region of FGF8b which is analogous to other FGFs resides 20 amino acids downstream of the 11 amino acid N-terminal peptide. Many of the receptor-binding and heparin-binding regions of FGFs are distributed within the`core' region and there is also evidence that, for example, for FGF2 (or bFGF), the C-terminal sequences increase the potency of the protein molecule (Basilico and Moscatelli, 1992) . Considering these observations, it was not suprising to ®nd a lack of transforming or soft agar clonogenic activity of NIH3T3 cells transduced with the 34aa construct. It was, however, remarkable to ®nd that expression from this construct could signal survival factors in the NIH3T3 cells mimicking, to a large but not fully, the eect seen with the expression of the complete FGF8b protein. Similarly, it is interesting that expression from the 103aa, lacking approximately 60% of the C-terminal portion of the mature FGF8b protein, can eciently function in inducing morphologic transformation or in supporting survival in reduced serum of the NIH3T3 cells. It has, however, reduced activity in clonogenic assay compared to the full length protein. Thus, there is a gradation of biological activity of the expressed FGF8b peptides depending on the type of the biological assay and the extent of Cterminal deletion. It is most likely that the observed dierences in the biological activities are related to the strength and nature of the FGF receptor interactions with these truncated ligands. It is also possible that the survival phenotype observed is mediated by signaling pathways dierent than those responsible for cellular transformation. These and related matters await further investigations.
While the sense constructs displayed dierential biologic activity, each of the antisense constructs were virtually equal in the ability to reverse the phenotype of the NIH3T3 cells ectopically expressing FGF8b protein. Clearly the expression of the antisense RNA portions drastically reduced the FGF8b mRNA levels as documented in the Northern blots. The possibility that the reduction in FGF8b mRNA levels were associated with correspondingly decreased FGF8b protein, expression and secretion was examined by a biological assay as described before (Ghosh et al., 1996) . While NIH3T3 cells could be strongly transformed by exposure to the conditioned medium from the FGF8b-NIH3T3 cells, such media from FGF8b-NIH3T3 cells transfected with any of the antisense constructs failed to induce transformation (data not shown). These ®ndings, however, remain to be con®rmed by direct estimation of the expressed FGF8 protein which is dicult to do at this time because of the lack of good antibodies against FGF8. Still, virtually complete reversion of the FGF8b induced phenotype of the NIH3T3 cells by the antisense FGF8b constructs provides good evidence for the speci®city of the eect. The results obtained with the series of experiments conducted on DU145 cells provide the ®rst evidence that antisense FGF8 RNA expression in prostate carcinoma cells can inhibit their growth in cell culture and their ability to grow in soft agar. Overexpression of the sense 215aa, on the other hand, appears to only minimally stimulate the parental DU145 cells in these biological assays. The reasons for this are not known, although they might potentially concern a limitation of appropriate receptor expression levels. Consistent with the in vitro results of sense 215aa expression in DU145 cells, these transformed cells were also only slightly more ecient in ectopic tumorgenicity when inoculated s.c. into athymic mice with respect to reduced latency DU145 cells separately infected with vector control, sense 215aa and antisense 215aa virus were infected s.c. into the left inguinal region of male nude mice (3 weeks old) at 10 6 cells per animal. The mice were monitored weekly for tumor formation and sacri®ced after 5 weeks. The tumors were excised and their volumes were measured by multiplying length6width6depth and expressed as mm 3 compared to vector-transduced cells. It should, however, be noted that epithelial-mesenchymal crosstalk may be critical in tumorigenesis. For example, FGF-7 is reported to be a paracrine growth factor induced in stromal cells by androgen in a rat prostate cancer model (Yan et al., 1992) . It is also postulated that epithelially produced FGF8 isoforms interact with receptors which are expressed mesenchymally (Blunt et al., 1997) . Furthermore, reports exists that prostate cancer cell line mediated tumor growth in athymic mice is dependent on coinjection of prostate or bone speci®c ®broblasts (Gleave et al., 1991 (Gleave et al., , 1992 . Perhaps, future work with sense FGF8b-transduced DU145 cells in either the model of coinjected cells or by direct intraprostatic injection (orthotopic) of the transduced epithelial cells will better de®ne the role of overexpressed FGF8b in tumorigenicity. Despite the inherent limitations of the s.c. tumorigenicity experiments, it is most remarkable that expression of the antisense construct in the present experiments could either inhibit DU145 tumor growth or prolong the latency in tumor development. Pooled antisenseexpressing DU145 cell colonies, rather than individual single cell clones, were used in the tumor induction experiments. Therefore, possibility exists that the delayed tumor development in some of the animals could be related to in vivo selection of cells which either produces less amounts of the antisense mRNAs or which might have undergone antisense silencing due to various factors which are known to inactivate gene expression through retroviral vectors. All in all, our ®ndings with the DU145 cells suggest that the FGF8 gene might play a critical role in maintaining the tumorigenic phenotype of the prostate cancer cells. Potentially, this gene function may be a target for prostate cancer prevention and therapy.
